Tatsuki R Kataoka

Summary

Affiliation: Graduate School
Country: Japan

Publications

  1. doi request reprint CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto, Japan
    Int Immunol 27:95-103. 2015
  2. doi request reprint PD-1 regulates the growth of human mastocytosis cells
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Allergol Int 62:99-104. 2013
  3. pmc CD72 negatively regulates KIT-mediated responses in human mast cells
    Tatsuki R Kataoka
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 184:2468-75. 2010
  4. doi request reprint The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion
    Chiyuki Ueshima
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Cancer Immunol Res 3:871-80. 2015
  5. doi request reprint NKp46 regulates the production of serine proteases and IL-22 in human mast cells in urticaria pigmentosa
    Chiyuki Ueshima
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Exp Dermatol 24:675-9. 2015
  6. pmc CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Sci Rep 3:2861. 2013
  7. pmc Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
    Eiji Suzuki
    Department of Breast Surgery, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    BMC Cancer 15:39. 2015
  8. pmc An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto 606 8507, Japan
    World J Surg Oncol 12:186. 2014
  9. doi request reprint Variegated RHOA mutations in adult T-cell leukemia/lymphoma
    Yasunobu Nagata
    Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Blood 127:596-604. 2016

Collaborators

Detail Information

Publications9

  1. doi request reprint CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto, Japan
    Int Immunol 27:95-103. 2015
    ..6 activated Cbl-b, down-regulated KIT expression and suppressed the mutated KIT-driven growth of these cells. Thus, the mechanism by which CD72 mediates inhibitory effects in mast cells is species-dependent. ..
  2. doi request reprint PD-1 regulates the growth of human mastocytosis cells
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Allergol Int 62:99-104. 2013
    ..Programmed death-1 (PD-1) is a marker for human neoplastic T cells. Here, we evaluated whether or not PD-1 was also a marker for human mastocytosis, and explored the role of PD-1 in human mastocytosis cells...
  3. pmc CD72 negatively regulates KIT-mediated responses in human mast cells
    Tatsuki R Kataoka
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 184:2468-75. 2010
    ..Furthermore, BU40 and rCD100 also downregulated the growth of the HMC1.2 human mast cell line. Thus, targeting CD72 may provide a novel approach to the suppression of mast cell disease such as mastocytosis...
  4. doi request reprint The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion
    Chiyuki Ueshima
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Cancer Immunol Res 3:871-80. 2015
    ..7%; χ(2) = 7.439; P < 0.01; degrees of freedom, 1) in the clinical samples. These findings suggest that the KIR2DL4 on human mast cells facilitates HLA-G-expressing cancer invasion and the subsequent metastasis...
  5. doi request reprint NKp46 regulates the production of serine proteases and IL-22 in human mast cells in urticaria pigmentosa
    Chiyuki Ueshima
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Exp Dermatol 24:675-9. 2015
    ..An agonistic anti-NKp46 antibody upregulated production of GrB and IL-22, but did not change the MCT-like phenotype of HMC1.2 cells. NKp46 was thus involved in the production of serine proteases and IL-22 in human mast cells. ..
  6. pmc CD72 regulates the growth of KIT-mutated leukemia cell line Kasumi-1
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan
    Sci Rep 3:2861. 2013
    ..Thus, these results seemed to suggest that CD72 was the therapeutic potential for AML, as is the case of MCTs. ..
  7. pmc Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
    Eiji Suzuki
    Department of Breast Surgery, Kyoto University Hospital, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto, 606 8507, Japan
    BMC Cancer 15:39. 2015
    ....
  8. pmc An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall
    Tatsuki R Kataoka
    Department of Diagnostic Pathology, Kyoto University Hospital, Sakyo ku, Kyoto 606 8507, Japan
    World J Surg Oncol 12:186. 2014
    ..Therefore, IMTs should be included in the differential diagnosis of spindle cell tumors, even those that are KIT-positive. ..
  9. doi request reprint Variegated RHOA mutations in adult T-cell leukemia/lymphoma
    Yasunobu Nagata
    Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Blood 127:596-604. 2016
    ..In summary, our study not only provides a novel insight into the molecular pathogenesis of ATLL but also highlights a unique role of variegation of heterologous RHOA mutations in human cancers. ..